跳至主要内容
临床试验/NCT06871280
NCT06871280已完成不适用

Assessment of Vertigo and Dizziness in Individuals Following COVID-19

Istanbul Physical Medicine Rehabilitation Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 296 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
296
试验地点
1
主要终点
Dizziness Handicap Inventory

研究概览

简要总结

This cross-sectional study aimed to assess the prevalence of dizziness/vertigo in individuals following COVID-19 and to investigate potential risk factors associated with these symptoms. A total of 296 patients aged 20-66 years who had recovered from COVID-19 were evaluated at Istanbul Physical Medicine and Rehabilitation Training and Research Hospital between June 1, 2021, and December 31, 2021. Clinical and demographic data, including COVID-19 history, comorbidities, and symptom characteristics, were collected. Dizziness-related disability was assessed using the Dizziness Handicap Inventory (DHI), while balance performance was evaluated with the Berg Balance Scale (BBS).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 66 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Individuals aged 20-66 years.
  • •History of confirmed COVID-19 infection.
  • •Ability to speak and understand Turkish.
  • •Willingness to provide verbal and written informed consent.

排除标准

  • •Pre-existing vertigo or balance disorders (e.g., benign paroxysmal positional vertigo, Ménière's disease, vestibular migraine, vestibular neuritis).
  • •Inner ear diseases or vestibular dysfunction.
  • •Neurological disorders affecting balance (e.g., multiple sclerosis, Parkinson's disease, history of stroke, epilepsy).
  • •Psychiatric conditions that could cause dizziness (e.g., anxiety, panic attacks, depression).
  • •History of head or neck trauma in the past six months.
  • •Moderate to severe visual impairment.
  • •Chronic alcohol or substance use.
  • •Use of ototoxic medications.
  • •Severe cardiovascular diseases (e.g., orthostatic hypotension, advanced heart failure, severe arrhythmias).
  • •Pregnant or breastfeeding women.
  • •Acute infection other than COVID-19 in the past three months.
  • •Severe COVID-19 requiring hospitalization

结局指标

主要结局

Dizziness Handicap Inventory

时间窗: 0 day

Prevalence of dizziness/vertigo in individuals following COVID-19, assessed using the Dizziness Handicap Inventory (DHI). Range: 0-100 (Higher scores indicate greater dizziness-related disability).

次要结局

  • Berg Balance Scale (BBS)(0 day)

研究者

发起方
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验